Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound.

A physical method using ultrasound (US) and nano/microbubbles (NBs) can deliver exogenous molecules noninvasively into a specific target site. In this study, we evaluated the application of this technology to cancer gene therapy using prodrug activation therapy. Low-intensity pulsed ultrasound (1 MHz; 1.3 W/cm(2)) and NBs were used to transduce the herpes simplex thymidine kinase (HSVtk) gene in vitro, leading to gene transfer. The addition of ganciclovir (GCV) to the transduced cells led to HSVtk/GCV-dependent cell death mediated by apoptosis. This technology was then assessed in vivo, using mice bearing subcutaneous tumors (1 MHz; 3.0 W/cm(2)). Gene transfer to the tumor, measured by luciferase activity, was transient, with a peak of expression 24 h after transduction, and decreased at 48 h, demonstrating the transient nature of US/NB-mediated gene transfer. The therapeutic potential of this approach was evaluated through repeated intratumoral gene delivery using US/NB-mediated transfer of the HSVtk gene, followed by recurrent administration of GCV, using two different experimental treatment protocols. In both cases, dramatic reductions of the tumor size by a factor of four were observed. Altogether, these data demonstrate the potential of US/NB as a new physical gene delivery method for cancer gene therapy. (E-mail: kodama@tubero.tohoku.ac.jp).

[1]  G. Vassaux,et al.  Use of suicide genes for cancer gene therapy: study of the different approaches , 2004, Expert opinion on biological therapy.

[2]  N. Lemoine,et al.  Noninvasive Imaging of the Transcriptional Activities of Human Telomerase Promoter Fragments in Mice , 2004, Cancer Research.

[3]  S. L. Bridal,et al.  Ultrasonic contrast agent shell rupture detected by inertial cavitation and rebound signals , 2006, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[4]  W. Hamel,et al.  Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. , 1996, Cancer research.

[5]  Michael R Hamblin,et al.  Delivery of ribosome-inactivating protein toxin into cancer cells with shock waves. , 2003, Cancer letters.

[6]  M. McCulloch,et al.  Ultrasound contrast physics: A series on contrast echocardiography, article 3. , 2000, Journal of the American Society of Echocardiography.

[7]  W. Pitt,et al.  Ultrasonic drug delivery – a general review , 2004, Expert opinion on drug delivery.

[8]  A. Söling,et al.  A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma , 2004, Genetic vaccines and therapy.

[9]  B. Sangro,et al.  Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. , 2003, Current gene therapy.

[10]  A. George,et al.  Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles. , 2005, Ultrasound in medicine & biology.

[11]  N. Lemoine,et al.  Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. , 2002, Human gene therapy.

[12]  Jonathan R. Lindner,et al.  Microbubbles in medical imaging: current applications and future directions , 2004, Nature Reviews Drug Discovery.

[13]  Q. Lu,et al.  Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents. , 2005, Radiology.

[14]  K. Kataoka,et al.  Polyion complex micelles as vectors in gene therapy – pharmacokinetics and in vivo gene transfer , 2002, Gene Therapy.

[15]  G. Vassaux,et al.  A non‐invasive tissue‐specific molecular delivery method of cancer gene therapy , 2006, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[16]  Juthamas Sukbuntherng,et al.  In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  C. Crumpacker,et al.  Inhibition of HSV-transformed murine cells by nucleoside analogs, 2'-NDG and 2'-nor-cGMP: mechanisms of inhibition and reversal by exogenous nucleosides. , 1985, Virology.

[18]  P. Dayton,et al.  Mechanisms of contrast agent destruction , 2001, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[19]  S. Tejpar,et al.  Assessment of endostatin gene therapy for familial adenomatous polyposis-related desmoid tumors. , 2006, Cancer research.

[20]  D. Harrison,et al.  Ganciclovir-induced ablation non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis. , 1996, Oncogene.

[21]  N. Lemoine,et al.  Insulation of a conditionally expressed transgene in an adenoviral vector , 1999, Gene Therapy.

[22]  Robert J. Eckersley,et al.  Developments in ultrasound contrast media , 2001, European Radiology.

[23]  H. Yamasaki,et al.  Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. , 2000, Cancer research.

[24]  H. Schaeffer,et al.  Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. , 1981, Biochemical pharmacology.

[25]  J. Wu,et al.  Experimental study of stability of a contrast agent in an ultrasound field. , 1998, Ultrasound in medicine & biology.

[26]  K. Tachibana,et al.  Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice--initial results. , 2003, Radiology.

[27]  E. Kobayashi,et al.  Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume , 2006, Gene Therapy.

[28]  T. Kodama,et al.  Spinal gene transfer using ultrasound and microbubbles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[29]  X. -. Chen,et al.  Combination gene therapy for liver metastasis of colon carcinoma in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Sam S. Yoon,et al.  Influence of p53 on herpes simplex virus type 1 vectors for cancer gene therapy , 1999, Journal of Gastrointestinal Surgery.

[31]  Yukio Tomita,et al.  Transfection effect of microbubbles on cells in superposed ultrasound waves and behavior of cavitation bubble. , 2006, Ultrasound in medicine & biology.

[32]  S. Freeman,et al.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. , 1993, Cancer research.